OM
Opaleye Management’s Avalo Therapeutics AVTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-450,000
| Closed | -$225K | – | 43 |
|
|
2022
Q2 | $225K | Sell |
450,000
-1,004,400
| -69% | -$502K | 0.1% | 44 |
|
|
2022
Q1 | $1.05M | Sell |
1,454,400
-5,000
| -0.3% | -$3.62K | 0.33% | 40 |
|
|
2021
Q4 | $2.48M | Hold |
1,459,400
| – | – | 0.53% | 35 |
|
|
2021
Q3 | $3.18M | Sell |
1,459,400
-108,094
| -7% | -$236K | 0.59% | 34 |
|
|
2021
Q2 | $5.13M | Sell |
1,567,494
-1,032,506
| -40% | -$3.38M | 0.85% | 32 |
|
|
2021
Q1 | $7.85M | Sell |
2,600,000
-20,000
| -0.8% | -$60.4K | 1.15% | 26 |
|
|
2020
Q4 | $6.92M | Sell |
2,620,000
-752,500
| -22% | -$1.99M | 0.9% | 30 |
|
|
2020
Q3 | $7.68M | Hold |
3,372,500
| – | – | 1.5% | 27 |
|
|
2020
Q2 | $8.77M | Buy |
3,372,500
+1,169,400
| +53% | +$3.04M | 1.77% | 20 |
|
|
2020
Q1 | $5.46M | Buy |
2,203,100
+12,426
| +0.6% | +$30.8K | 1.45% | 20 |
|
|
2019
Q4 | $11.8M | Buy |
2,190,674
+5,138
| +0.2% | +$27.7K | 2.32% | 18 |
|
|
2019
Q3 | $7.19M | Hold |
2,185,536
| – | – | 2.6% | 20 |
|
|
2019
Q2 | $11.2M | Sell |
2,185,536
-114,464
| -5% | -$585K | 3.41% | 10 |
|
|
2019
Q1 | $13.4M | Buy |
2,300,000
+114,464
| +5% | +$668K | 3.72% | 4 |
|
|
2018
Q4 | $6.21M | Buy |
+2,185,536
| New | +$6.21M | 2.32% | 14 |
|